{"name":"DNA Therapeutics","slug":"dna-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQejdCYUQ5dzRaVkQ2UG5MLUFvOW9oQVM5ckh4TEt3SkJFWHhJTk0wZ29xVi1zcEhFVXRQLWxxYjlGNDQwdlVrZVpJSzRGcFVLcW9tUG1LSEhHOGNpUnhVMzk0UVRpd0ViY2d0dURFWDNPd0VpdHktSTVPSWY2SWFOR0pqMWlfVjVPYzlzc29zdTZ4N0xXb2VpY1lR?oc=5","date":"2026-03-25","type":"pipeline","source":"Britannica","summary":"Genetically modified organism - Medicine, Research, Biotechnology - Britannica","headline":"Genetically modified organism - Medicine, Research, Biotechnology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQR1FzekprVDAwd1g0UV9RZU1neERhc2w1ZW50SGtSamVPRFNpeHhucEdrTUdlXzBWWXNOWW5RQVVaT3lJYlFLVmhJSEpUemV0RW1jNFE3TWlzenVFbDZmaHpDMi1GQU5LR0I3TFI5a1lsUThUeG9PQ296d0VjTjZVUDA0Z2VhTm55Z0lR?oc=5","date":"2026-02-24","type":"patent","source":"Yahoo Finance","summary":"Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors - Yahoo Finance","headline":"Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQaEpiV2ZZeG5wRGprbmRXQmtqM1hSdVFLd2loaVpwbHR5THBMSlExTUtpd0xxWGRxdGd4ZThTLS1hcmo5YzB2dG1EX2ZvdkphWE5TMmR2c0RybnpjZ25lLXNKLWYxSDZGdG9BbU42WTdDMFdUOVRqUkFmNEJNVFhZMXRkVjFZSGg2eFhHZ2RR?oc=5","date":"2026-02-23","type":"pipeline","source":"The Motley Fool","summary":"Is Inovio Pharmaceuticals Stock Going to $0? - The Motley Fool","headline":"Is Inovio Pharmaceuticals Stock Going to $0?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNQmIxN25wdTB0X1lxRHBuUkZFLVZnbW1CM1E1UmlhTVREVGN6cDVQN0t6aktaVzFuTEdrLWhVdEFCUGtPWjZjWmRwUUpmd1hDTDJaQ19uVHNrM2dIVHEzZ0dTTklJUVczWGdUb2RGb2RRSlB0Sk9rVk5IakJMQ1lkT0tycEx5UW9xTVo3bERGVUVVNHVsbTJLaGpfNFBKUmNNbmxNMS1JWGxQMndYTzJRbkN1MFBHdE56T09Z?oc=5","date":"2026-02-02","type":"patent","source":"Stock Titan","summary":"Acurx patent backs new antibiotics for C. diff and MRSA - Stock Titan","headline":"Acurx patent backs new antibiotics for C. diff and MRSA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPUVJ0UTl4RjV5NXZka3R4LVlJS045dHBUSnI3Qnh0QzlLWDhSWnFSWFJVcldTWThjM1lETFFoYlJlWjRLTW02ZTk4bXNwajkwOGVONGJTZU9rVVk4UUpPRlpWZjJWXzhON1hncmNTbmVQQzM0czl3NXB4OXdEczJGc3k0Ym5lNGFESVRiajlwZmhPTERJMG1PN01HbF9aZkdraWNnZ01ES2ZGdEIybS1mNzVnMA?oc=5","date":"2026-01-08","type":"pipeline","source":"Fierce Pharma","summary":"Acuitas takes majority stake in Montreal-based RNA construct manufacturer - Fierce Pharma","headline":"Acuitas takes majority stake in Montreal-based RNA construct manufacturer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOTmZvQ1JrdWpIQkpEekJsWWNzbWRSUVpoaDhnSUJtODgxSzA5dmN4NDBrcFhRY2NsYlR5UjdpTG1wMEswTWR3Tm01VTd4a0UxV25Ib282VG5xMTd6NHRoODJTOUJ1ZEFoRXdTV0VGb0tSZHB0a1hCSXZUX0dMZmZMWXZ5aGtRS2RzZl9DcEJVRkJhT3dyWmkzSEJLWjY3a2JoYlBUbGI2eU5Nc3h6TmJQQ3FRRnBiZWpNdHFCM1QyQ1d2OFk?oc=5","date":"2025-11-17","type":"pipeline","source":"Fierce Biotech","summary":"Artios Pharma secures $115M series D to ramp up clinical efforts with DNA damage response pipeline - Fierce Biotech","headline":"Artios Pharma secures $115M series D to ramp up clinical efforts with DNA damage response pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9CWWRTdmw2WUZfbkQ1WnFyLXNpU19Qb25RbldrX0hJSnBfWG5NMTdFdXktUDNVV0lQYUVsaVdIRFhhRU5mN1FSQWJLVHNfM25UWFNZVWd6TU5aUDFJMFB6YjBTOHhia3M3WVdRYjZTVms5VW5ldm4wUDdwUGptcnc?oc=5","date":"2025-11-05","type":"pipeline","source":"Pharma Voice","summary":"Imunon’s non-viral DNA candidate may have cracked the code in frontline ovarian cancer - Pharma Voice","headline":"Imunon’s non-viral DNA candidate may have cracked the code in frontline ovarian cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxNRjhBMjZnWDF6YTMtZ1RwM3hqb19BaDA1bXVNVnRRdk1iWXp6VWRsYzQ1MlZWQXVwaFZyUkl5bHNGNk9zZWRzc0hHbnZxSjJfbUpIZVJLSjAzSmhjY0YwRGJwUVVySW5IeWw2MUNKTjRQTjVwN2laSFdTVS10dm85V1BqZk9HNm5TQm5GNGFZT0VjVzg4b3lGeUJ2eHJBTjQzQ2VzMEZsQlhGMjhtcXd1VHZoS2NPdVpxWG1RbXZrem5SUlpxenNOdEE3SXhDa0M2emNINlQycE1QMG8?oc=5","date":"2025-08-13","type":"pipeline","source":"Investing.com","summary":"Inovio Pharmaceuticals’ SWOT analysis: dna immunotherapy firm’s stock faces pivotal year - Investing.com","headline":"Inovio Pharmaceuticals’ SWOT analysis: dna immunotherapy firm’s stock faces pivotal year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQRGNXSG5INXIydTEybE5Dd1lzOHd0a2hhbW9xZDUzY1lFNG10X1R2Z3BYVWFEUW00dDEyVWI2Y1hBbVZNTzVaY1FnUzV0cXN4aUNLSThad3VzV1dYNDktN3RGTzlIbVZJeEczNDZ1TW5YYXlEOGVWTzZyVWptbGp6U2NFMnB2a293ZldiNEtYVzZEd0tJZUlUVnpld21sN3MzdEE?oc=5","date":"2025-07-31","type":"pipeline","source":"BioSpace","summary":"Mitochondrial DNA Market to Reach USD 687.99 Million by 2034 - BioSpace","headline":"Mitochondrial DNA Market to Reach USD 687.99 Million by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNN2ROdjNieENJUG5NSERVbmtiX2w4QWZTZUV1OWUwcmliQWNvQXlHZVNXNVFWa2paRHlFSTNmcmJfMVltY2NsY2xZczNBazFJVUFiWjJZUXY1dXpnNmhOelBZRjktY2dtczBCemxpUjQzT0RVY1RLOGpKak9abk1iTGFhV2Ewb3VhNThwZl82ek1UTDZjeFVXa1dreEZ5bnNjT2hiWEFHcEtfbHBFZkdMbDhGVWRUSkpfR3dLX3hmNW1UeGxja0hVVGFpRmFBV3FJc1pYclk1QUxQay10S2w4M3RTbEdhcy01dlE?oc=5","date":"2025-06-19","type":"pipeline","source":"eatg.org","summary":"Immuno Cure and PharmaJet collaborate to advance a novel HIV therapeutic DNA vaccine using needle-free technology in humans - eatg.org","headline":"Immuno Cure and PharmaJet collaborate to advance a novel HIV therapeutic DNA vaccine using needle-free technology in hum","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNNmFJaTBTNUR5TTN1MmNpaEp0MEt4QnVYdDRraVkxaF85NHAyb3ZrZXUwa3RfYmcwRl9rNG1XT2hodFhyeTl0SER1d2FzZHhFaVV1SmloeDRQWlpvVGNPMW5YQ0Qyc1VkNHgwZGctMkhpd2NDaTFIb3kxMHQ4Ti1YXzZjZDY5RGUyQnRmblp1VWg?oc=5","date":"2025-05-29","type":"pipeline","source":"The New York Times","summary":"23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million - The New York Times","headline":"23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9EWEFrSTZ2NjRCQm55Rjc1YmEybVpXSk94ZzFRVUt3dERtRTRxUTh1SFQ1RmstQ1ZoclRYSzV2Nk1tTE11cnhrcTNGWEhKZG5uV0ZHRm9vSlpVNTFUUEZydGFBc0puMURwdm82TGU4YmJKZUdlMWlta1pn?oc=5","date":"2025-05-19","type":"trial","source":"Mashable","summary":"23andMe's trove of DNA data was just acquired by this pharma brand - Mashable","headline":"23andMe's trove of DNA data was just acquired by this pharma brand","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}